Huizenga Theodore Alan 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Transactions
- Gift
Common Stock
2024-12-10−648→ 41,840 total
Footnotes (2)
- [F1]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F2]Includes 237 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024.